Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1982 Sep;16(3):458–463. doi: 10.1128/jcm.16.3.458-463.1982

Serotypes of Pseudomonas aeruginosa in clinical specimens in relation to antibiotic susceptibility.

N J Legakis, M Aliferopoulou, J Papavassiliou, M Papapetropoulou
PMCID: PMC272389  PMID: 6813351

Abstract

Ninety-eight hospital strains of Pseudomonas aeruginosa isolated from six different hospitals in Athens were serotyped by a slide agglutination test with unabsorbed commercial antisera. Serotypes O6, O11, O12, and "pool E" strains (strains that agglutinated only in pool E, which contained antisera against O2, O5, O15, and O16 antigens, but did not agglutinate in the individual antisera) predominated, accounting for more than 62% of all isolates tested. In respect to serotypes, (i) there was no apparent correlation with hospital of origin, (ii) most strains of serotypes O6 and O11 were sensitive to gentamicin and carbenicillin (iii) most strains of pool E were from urine and were resistant to these drugs, (iv) all 9 strains of serotype O12 tested were resistant to carbenicillin and all 5 strains tested hydrolyzed this drug, and (v) 24 of 25 strains of pool E were resistant to carbenicillin but only 2 of 17 strains hydrolyzed it.

Full text

PDF
458

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
  2. Bennett J. V. Nosocomial infections due to Pseudomonas. J Infect Dis. 1974 Nov;130 (Suppl)(0):S4–S7. doi: 10.1093/infdis/130.supplement.s4. [DOI] [PubMed] [Google Scholar]
  3. Bergan T. Epidemiological markers for Pseudomonas aeruginosa. 3. Comparison of bacteriophage typing, serogrouping, and pyocine typing on a heterogeneous clinical material. Acta Pathol Microbiol Scand B Microbiol Immunol. 1973 Feb;81(1):91–101. [PubMed] [Google Scholar]
  4. Brokopp C. D., Gomez-Lus R., Farmer J. J., 3rd Serological typing of Pseudomonas aeruginosa: use of commercial antisera and live antigens. J Clin Microbiol. 1977 Jun;5(6):640–649. doi: 10.1128/jcm.5.6.640-649.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chadwick P. Resistance of Pseudomonas aeruginosa to gentamicin. Can Med Assoc J. 1973 Oct 6;109(7):585–587. [PMC free article] [PubMed] [Google Scholar]
  6. Chester I. R., Meadow P. M., Pitt T. L. The relationship between the O-antigenic lipopolysaccharides and serological specificity in strains of Pseudomonas aeruginosa of different O-serotypes. J Gen Microbiol. 1973 Oct;78(2):305–318. doi: 10.1099/00221287-78-2-305. [DOI] [PubMed] [Google Scholar]
  7. Denis F. A. Contamination of shellfish with strains of Pseudomonas aeruginosa and specific bacteriophages. Can J Microbiol. 1975 Jul;21(7):1055–1057. doi: 10.1139/m75-156. [DOI] [PubMed] [Google Scholar]
  8. Duncan N. H., Hinton N. A., Penner J. L., Duncan I. B. Preparation of typing antisera specific for O antigens of Pseudomonas aeruginosa. J Clin Microbiol. 1976 Aug;4(2):124–128. doi: 10.1128/jcm.4.2.124-128.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Farmer J. J., 3rd, Herman L. G. Epidemiological fingerprinting of Pseudomonas aeruginosa by the production of and sensitivity of pyocin and bacteriophage. Appl Microbiol. 1969 Nov;18(5):760–765. doi: 10.1128/am.18.5.760-765.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Finland M. Changing ecology of bacterial infections as related to antibacterial therapy. J Infect Dis. 1970 Nov;122(5):419–431. doi: 10.1093/infdis/122.5.419. [DOI] [PubMed] [Google Scholar]
  11. Gillies R. R., Govan J. R. Typing of Pseudomonas pyocyanea by pyocine production. J Pathol Bacteriol. 1966 Apr;91(2):339–345. doi: 10.1002/path.1700910207. [DOI] [PubMed] [Google Scholar]
  12. Greene W. H., Moody M., Schimpff S., Young V. M., Wiernik P. H. Pseudomonas aeruginosa resistant to carbenicillin and gentamicin. Epidemiologic and clinical aspects in a cancer center. Ann Intern Med. 1973 Nov;79(5):684–689. doi: 10.7326/0003-4819-79-5-684. [DOI] [PubMed] [Google Scholar]
  13. Grieble H. G., Colton F. R., Bird T. J., Toigo A., Griffith L. G. Fine-particle humidifiers. Source of Pseudomonas aeruginosa infections in a respiratory-disease unit. N Engl J Med. 1970 Mar 5;282(10):531–535. doi: 10.1056/NEJM197003052821003. [DOI] [PubMed] [Google Scholar]
  14. HABS I. Untersuchungen über die O-Antigene von Pseudomonas aeruginosa. Z Hyg Infektionskr. 1957;144(3):218–228. [PubMed] [Google Scholar]
  15. Homma J. Y., Shionoya H., Yamada H., Kawabe Y. Production of antibody against Pseudomonas aeruginosa and its serological typing. Jpn J Exp Med. 1971 Feb;41(1):89–94. [PubMed] [Google Scholar]
  16. Legakis N. J., Tselentis J., Courtis K. J., Papavassiliou J. Cross-resistance of clinical isolates of Pseudomonas aeruginosa to five aminoglycosides. J Antimicrob Chemother. 1979 Jul;5(4):487–490. doi: 10.1093/jac/5.4.487. [DOI] [PubMed] [Google Scholar]
  17. Lianou P. E., Bassaris H. P., Daikos G. K., Katsorchis T. A., Legakis N. J. Increased adherence to human epithelial cells of resistant Pseudomonas aeruginosa strains. J Infect. 1980 Dec;2(4):354–359. doi: 10.1016/s0163-4453(80)92816-9. [DOI] [PubMed] [Google Scholar]
  18. Lindberg R. B., Latta R. L. Phage typing of Pseudomonas aeruginosa: clinical and epidemiologic considerations. J Infect Dis. 1974 Nov;130 (Suppl)(0):S33–S42. doi: 10.1093/infdis/130.supplement.s33. [DOI] [PubMed] [Google Scholar]
  19. Meitert T. Contribution à l'étude de la structure antigénique des B. Pyocyaniques (Pseudomonas aeruginosa) Arch Roum Pathol Exp Microbiol. 1964 Sep;23(3):679–688. [PubMed] [Google Scholar]
  20. Meyer R. D., Draus L. L., Pasieczinik K. A. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics. Antimicrob Agents Chemother. 1976 Oct;10(4):677–681. doi: 10.1128/aac.10.4.677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pitt T. L., Erdman Y. J. The specificity of agglutination reactions of Pseudomonas aeruginosa with O antisera. J Med Microbiol. 1978 Feb;11(1):15–23. doi: 10.1099/00222615-11-1-15. [DOI] [PubMed] [Google Scholar]
  22. Pitt T. L. State of the art: typing Pseudomonas aeruginosa. J Hosp Infect. 1980 Sep;1(3):193–199. doi: 10.1016/0195-6701(80)90056-0. [DOI] [PubMed] [Google Scholar]
  23. SUTTER V. L., HURST V., FENNELL J. A STANDARDIZED SYSTEM FOR PHAGE TYPING PSEUDOMONAS AERUGINOSA. Health Lab Sci. 1965 Jan;2:7–16. [PubMed] [Google Scholar]
  24. Sanchez-Buenaventura J., Patino J., Marti A., Mustieles M. L. Incidence des groupes antigéniques "O" de Pseudomonas aeruginosa dans la province de Valencia (Espagne). Ann Microbiol (Paris) 1978 Feb-Mar;129(2):161–165. [PubMed] [Google Scholar]
  25. Stamm W. E., Martin S. M., Bennett J. V. Epidemiology of nosocomial infection due to Gram-negative bacilli: aspects relevant to development and use of vaccines. J Infect Dis. 1977 Aug;136 (Suppl):S151–S160. doi: 10.1093/infdis/136.supplement.s151. [DOI] [PubMed] [Google Scholar]
  26. Ullmann U., Schmülling R. M. Distribution of Pseudomonas aeruginosa serotypes in bacteriologic specimens and their aminoglycoside resistance. Zentralbl Bakteriol A. 1980;247(2):241–247. [PubMed] [Google Scholar]
  27. VERDER E., EVANS J. A proposed antigenic schema for the identification of strains of Pseudomonas aeruginosa. J Infect Dis. 1961 Sep-Oct;109:183–193. doi: 10.1093/infdis/109.2.183. [DOI] [PubMed] [Google Scholar]
  28. Vieu J. F., Vieu M., Hsssan-Massoud B. Epidémiologie de Pseudomonas aeruginosa en Egypte : étude de 80 souches d'origine hospitalière isolées a Alexandrie. Bull Soc Pathol Exot Filiales. 1978 Jan-Feb;71(1):48–54. [PubMed] [Google Scholar]
  29. Weinstein R. A., Nathan C., Gruensfelder R., Kabins S. A. Endemic aminoglycoside resistance in gram-negative bacilli: epidemiology and mechanisms. J Infect Dis. 1980 Mar;141(3):338–345. doi: 10.1093/infdis/141.3.338. [DOI] [PubMed] [Google Scholar]
  30. Whitby J. L., Rampling A. Pseudomonas aeruginosa contamination in domestic and hospital environments. Lancet. 1972 Jan 1;1(7740):15–17. doi: 10.1016/s0140-6736(72)90006-2. [DOI] [PubMed] [Google Scholar]
  31. Young V. M., Moody M. R. Serotyping of Pseudomonas aeruginosa. J Infect Dis. 1974 Nov;130 (Suppl)(0):S47–S52. doi: 10.1093/infdis/130.supplement.s47. [DOI] [PubMed] [Google Scholar]
  32. Zabransky R. J., Day F. E. Pyocine typing of clinical strains of Pseudomonas aeruginosa. Appl Microbiol. 1969 Feb;17(2):293–296. doi: 10.1128/am.17.2.293-296.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. von Graevenitz A. The role of opportunistic bacteria in human disease. Annu Rev Microbiol. 1977;31:447–471. doi: 10.1146/annurev.mi.31.100177.002311. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES